Cabot gets into pharma with $1.1 billion Norit buy; Nidek oxygen tanks have fire risk;

> Cabot will pay $1.1 billion for the Netherlands-based Norit, which, among other things, makes chemicals for pharmaceuticals. Story

> Nidek Medical Products has recalled some of its supplemental oxygen tanks because of fire risks. FDA recall

> Skystar Bio-Pharmaceutical in China says its veterinary drug manufacturing plant there has been approved by regulators. Item

> The state government in Himachal Pradesh is reportedly cracking down on drug manufacturers there that produce many of the drugs for India's domestic market, but which have often failed standards tests. Item

And Finally... McKesson, which as a distributor handled Merck's NuvaRing contraceptive device, has found itself caught up in legal maneuverings over jurisdiction of lawsuits brought by plaintiffs who claim that they were hurt by the device. Story

Suggested Articles

Hikma says it has picked up some pipeline products and nasal and sublingual spray equipment from Insys Therapeutics' bankruptcy.

WuXi Biologics expects to have a plant in Europe complete in 2021 as a capacity race plays out among Asia’s rapidly growing biologics CDMOs.

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.